1. High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1. (December 2020) Authors: Muñoz-Unceta, Nerea; Zugazagoitia, Jon; Manzano, Arancha; Jiménez-Aguilar, Elisabeth; Olmedo, María E.; Cacho, Juan D.; Oliveira, Julio; Dómine, Manuel; Ortega-Morán, Laura; Aguado, Carlos; Luna, Ana M.; Fernández, Lourdes; Pérez, Javier; Font, Carme; Salvador, Carmen; Corral, Jesús; Benítez, Gre... Journal: European journal of cancer Issue: Volume 141(2020) Page Start: 193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer. Issue 5 (3rd May 2018) Authors: Zugazagoitia, Jon; Biosca, Mercedes; Oliveira, Julio; Olmedo, María Eugenia; Dómine, Manuel; Nadal, Ernest; Ruffinelli, José Carlos; Muñoz, Nerea; Luna, Ana María; Hernández, Berta; Martínez, Maite; Gallego, Iria; Martínez de Castro, Eva; Font, Carme; Calvo, Virginia; Martínez-Marín, Virginia; Co... Journal: European respiratory journal Issue: Volume 51:Issue 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer. (December 2019) Authors: Pérol, Maurice; Pavlakis, Nick; Levchenko, Evgeny; Platania, Marco; Oliveira, Julio; Novello, Silvia; Chiari, Rita; Moran, Teresa; Mitry, Emmanuel; Nüesch, Eveline; Liu, Ting; Balas, Bogdana; Konopa, Krzysztof; Peters, Solange Journal: Lung cancer Issue: Volume 138(2019) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗